International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 4 , Pages 1046-1052, 15 July 2010

Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group

This work was presented in part at the 45th meeting of the American Society of Clinical Oncology, Orlando FL, May 29 - June 2, 2009.

  • Paul L. Nguyen, M.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
    • Corresponding Author InformationReprint requests to: Paul L. Nguyen, M.D., Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. Tel: (617) 732-6310; Fax: (617) 732-7347
  • ,
  • Ming-Hui Chen, Ph.D.

      Affiliations

    • Department of Statistics, University of Connecticut, Storrs, Connecticut
  • ,
  • Clair J. Beard, M.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • W. Warren Suh, M.D., M.P.H.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • Andrew A. Renshaw, M.D.

      Affiliations

    • Department of Pathology, Baptist Hospital of Miami, Miami, Florida
  • ,
  • Marian Loffredo, R.N., B.S., O.C.N.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • Elizabeth McMahon, R.N., B.S.N.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
  • ,
  • Philip W. Kantoff, M.D.

      Affiliations

    • Department of Medical Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts
  • ,
  • Anthony V. D'Amico, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts
    • Harvard Medical School, Boston, Massachusetts

Received 22 March 2009; received in revised form 3 June 2009; accepted 4 June 2009. published online 27 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest: none.

PII: S0360-3016(09)00951-1

doi:10.1016/j.ijrobp.2009.06.038

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 4 , Pages 1046-1052, 15 July 2010